Search research articles
Contact Us
Filters
Showing results (111-120 of 119) with videos related to
Page
of 12
Sort By:
You have reached the last page of results.
This site can display upto 119 results.
Hemasphere
|
November 20, 2024
The incidence and clinical significance of monoclonal and oligoclonal protein bands in multiple myeloma patients after BCMA-CAR-T cell therapy: A retrospective study based on LEGEND-2
Rui Liu, Gongzhizi Gao, Hongli Chen, et al.
Frontiers of Medicine
|
October 2, 2019
Management of cytokine release syndrome related to CAR-T cell therapy
Hongli Chen, Fangxia Wang, Pengyu Zhang, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
|
May 7, 2016
[Comparison of the Effectiveness and Safety of Combined Chemotherapy with PEG-Asp for Treatment of ALL and T-NHL Patients]
Yan Xu, Jin Wang, Nan Yang, et al.
Acta Haematologica
|
October 10, 2019
High Expression Levels of Long Noncoding RNA Small Nucleolar RNA Host Gene 18 and Semaphorin 5A Indicate Poor Prognosis in Multiple Myeloma
Ling-Juan Huang, Ying Shen, Ju Bai, et al.
Journal of Medicinal Chemistry
|
November 21, 2023
Imidazolone as an Amide Bioisostere in the Development of β-1,3-<i>N</i>-Acetylglucosaminyltransferase 2 (B3GNT2) Inhibitors
Jeffrey J Jackson, Aaron C Siegmund, Wen-Ju Bai, et al.
Journal of Medical Case Reports
|
December 10, 2022
Five-year remission without disease progression in a patient with relapsed/refractory multiple myeloma with extramedullary disease treated with LCAR-B38M chimeric antigen receptor T cells in the LEGEND-2 study: a case report
Bai-Yan Wang, Wan-Hong Zhao, Yin-Xia Chen, et al.
Journal of Hematology & Oncology
|
December 22, 2018
A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma
Wan-Hong Zhao, Jie Liu, Bai-Yan Wang, et al.
Journal of Hematology & Oncology
|
July 6, 2022
Four-year follow-up of LCAR-B38M in relapsed or refractory multiple myeloma: a phase 1, single-arm, open-label, multicenter study in China (LEGEND-2)
Wan-Hong Zhao, Bai-Yan Wang, Li-Juan Chen, et al.
Emerging Infectious Diseases
|
May 3, 2011
Japanese encephalitis, Tibet, China
Yi-Xing Li, Ming-Hua Li, Shi-Hong Fu, et al.
Page
of 12
Search research articles
Search
Showing results (111-120 of 119) with videos related to
Sort By:
Page
of 12
You have reached the last page of results.
This site can display upto 119 results.
Hemasphere
|
November 20, 2024
The incidence and clinical significance of monoclonal and oligoclonal protein bands in multiple myeloma patients after BCMA-CAR-T cell therapy: A retrospective study based on LEGEND-2
Rui Liu, Gongzhizi Gao, Hongli Chen, et al.
Frontiers of Medicine
|
October 2, 2019
Management of cytokine release syndrome related to CAR-T cell therapy
Hongli Chen, Fangxia Wang, Pengyu Zhang, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
|
May 7, 2016
[Comparison of the Effectiveness and Safety of Combined Chemotherapy with PEG-Asp for Treatment of ALL and T-NHL Patients]
Yan Xu, Jin Wang, Nan Yang, et al.
Acta Haematologica
|
October 10, 2019
High Expression Levels of Long Noncoding RNA Small Nucleolar RNA Host Gene 18 and Semaphorin 5A Indicate Poor Prognosis in Multiple Myeloma
Ling-Juan Huang, Ying Shen, Ju Bai, et al.
Journal of Medicinal Chemistry
|
November 21, 2023
Imidazolone as an Amide Bioisostere in the Development of β-1,3-<i>N</i>-Acetylglucosaminyltransferase 2 (B3GNT2) Inhibitors
Jeffrey J Jackson, Aaron C Siegmund, Wen-Ju Bai, et al.
Journal of Medical Case Reports
|
December 10, 2022
Five-year remission without disease progression in a patient with relapsed/refractory multiple myeloma with extramedullary disease treated with LCAR-B38M chimeric antigen receptor T cells in the LEGEND-2 study: a case report
Bai-Yan Wang, Wan-Hong Zhao, Yin-Xia Chen, et al.
Journal of Hematology & Oncology
|
December 22, 2018
A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma
Wan-Hong Zhao, Jie Liu, Bai-Yan Wang, et al.
Journal of Hematology & Oncology
|
July 6, 2022
Four-year follow-up of LCAR-B38M in relapsed or refractory multiple myeloma: a phase 1, single-arm, open-label, multicenter study in China (LEGEND-2)
Wan-Hong Zhao, Bai-Yan Wang, Li-Juan Chen, et al.
Emerging Infectious Diseases
|
May 3, 2011
Japanese encephalitis, Tibet, China
Yi-Xing Li, Ming-Hua Li, Shi-Hong Fu, et al.
Page
of 12